Xenon Pharmaceuticals (XENE) News Today $38.55 -0.05 (-0.13%) As of 03:47 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock XENE Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Xenon Pharmaceuticals Inc. $XENE Shares Acquired by Affinity Asset Advisors LLCAugust 28 at 9:02 AM | marketbeat.comRussell Investments Group Ltd. Has $2.53 Million Stock Position in Xenon Pharmaceuticals Inc. $XENEAugust 27 at 3:39 AM | marketbeat.comXenon Pharmaceuticals Inc. $XENE Shares Sold by T. Rowe Price Investment Management Inc.August 26 at 4:49 AM | marketbeat.comEntryPoint Capital LLC Makes New $298,000 Investment in Xenon Pharmaceuticals Inc. $XENEAugust 25, 2025 | marketbeat.comDid Higher-Than-Expected Losses Just Shift Xenon Pharmaceuticals' (XENE) Investment Narrative?August 24, 2025 | finance.yahoo.comWellington Management Group LLP Has $127.13 Million Position in Xenon Pharmaceuticals Inc. $XENEAugust 24, 2025 | marketbeat.comXenon Pharmaceuticals Inc. $XENE Shares Sold by Atika Capital Management LLCAugust 23, 2025 | marketbeat.comCandriam S.C.A. Lowers Holdings in Xenon Pharmaceuticals Inc. $XENEAugust 23, 2025 | marketbeat.comXenon Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:XENE)August 23, 2025 | marketbeat.comXenon Pharmaceuticals Inc. $XENE Shares Sold by Algert Global LLCAugust 22, 2025 | marketbeat.comAn Intrinsic Calculation For Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Suggests It's 44% UndervaluedAugust 21, 2025 | finance.yahoo.comXenon Pharmaceuticals Inc. $XENE Shares Acquired by Aberdeen Group plcAugust 21, 2025 | marketbeat.comLord Abbett & CO. LLC Sells 106,990 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE)August 19, 2025 | marketbeat.comWhat is Chardan Capital's Forecast for XENE FY2025 Earnings?August 19, 2025 | marketbeat.comFY2025 Earnings Estimate for XENE Issued By Chardan CapitalAugust 18, 2025 | americanbankingnews.comXENE FY2025 EPS Estimate Decreased by Cantor FitzgeraldAugust 16, 2025 | marketbeat.comHC Wainwright Analysts Decrease Earnings Estimates for XENEAugust 16, 2025 | marketbeat.comQ3 EPS Estimate for Xenon Pharmaceuticals Lifted by AnalystAugust 16, 2025 | marketbeat.comWilliam Blair Has Negative Estimate for XENE Q3 EarningsAugust 16, 2025 | marketbeat.comWhat is William Blair's Estimate for XENE FY2027 Earnings?August 15, 2025 | marketbeat.comXenon Pharmaceuticals' (XENE) "Buy" Rating Reiterated at Chardan CapitalAugust 14, 2025 | marketbeat.comXenon Pharmaceuticals (NASDAQ:XENE) Shares Gap Up After Analyst UpgradeAugust 13, 2025 | marketbeat.comRoyal Bank Of Canada Has Lowered Expectations for Xenon Pharmaceuticals (NASDAQ:XENE) Stock PriceAugust 13, 2025 | marketbeat.comXenon Pharmaceuticals (NASDAQ:XENE) Given New $43.00 Price Target at WedbushAugust 13, 2025 | marketbeat.comTD Cowen Reaffirms Their Buy Rating on Xenon (XENE)August 13, 2025 | theglobeandmail.comXenon Completes Patient Recruitment for Phase 3 StudyAugust 13, 2025 | theglobeandmail.comXenon Pharmaceuticals (NASDAQ:XENE) Announces Quarterly Earnings ResultsAugust 12, 2025 | marketbeat.comXenon Pharmaceuticals price target lowered to $55 from $57 at RBC CapitalAugust 12, 2025 | msn.comXenon Pharmaceuticals: Pushing Azetukalner Towards Finish Line With Phase 3 2026 Data ReleaseAugust 12, 2025 | seekingalpha.comXenon Pharmaceuticals Reports Q2 2025 Progress and OutlookAugust 12, 2025 | msn.comXenon Pharmaceuticals Inc. (XENE) Q2 2025 Earnings Call TranscriptAugust 11, 2025 | seekingalpha.comXenon Pharmaceuticals: Q2 Earnings SnapshotAugust 11, 2025 | chron.comXenon Pharmaceuticals jumps after massive earnings beatAugust 11, 2025 | investing.comXenon Reports Second Quarter 2025 Financial Results & Business UpdateAugust 11, 2025 | globenewswire.comMutual of America Capital Management LLC Acquires Shares of 48,763 Xenon Pharmaceuticals Inc. (NASDAQ:XENE)August 11, 2025 | marketbeat.comXenon Pharma Q2 2025 Earnings PreviewAugust 11, 2025 | seekingalpha.com2XENE : A Look Ahead: Xenon Pharmaceuticals's Earnings ForecastAugust 8, 2025 | benzinga.comXenon Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:XENE)August 7, 2025 | marketbeat.comXenon Pharmaceuticals (XENE) Expected to Announce Earnings on MondayAugust 6, 2025 | marketbeat.comWestfield Capital Management Co. LP Has $46.68 Million Stock Holdings in Xenon Pharmaceuticals Inc. (NASDAQ:XENE)August 6, 2025 | marketbeat.comXenon Pharmaceuticals Issues Equity Inducement Grants to New EmployeesAugust 6, 2025 | theglobeandmail.comXenon Pharmaceuticals (NASDAQ:XENE) Trading 7.1% Higher - Still a Buy?August 5, 2025 | marketbeat.comXenon to Report Q2 2025 Financial Results on August 11, 2025August 4, 2025 | financialpost.comFXenon Pharmaceuticals Inc. (NASDAQ:XENE) Shares Sold by BIT Capital GmbHAugust 4, 2025 | marketbeat.comXenon to Report Q2 2025 Financial Results on August 11, 2025August 4, 2025 | globenewswire.comJ. Safra Sarasin Holding AG Has $1.03 Million Stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE)August 4, 2025 | marketbeat.comXenon Pharmaceuticals Inc. (NASDAQ:XENE) Given Consensus Rating of "Buy" by AnalystsAugust 4, 2025 | marketbeat.comXenon Pharmaceuticals Inc. (NASDAQ:XENE) Shares Sold by Federated Hermes Inc.August 3, 2025 | marketbeat.comShort Interest in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Expands By 6,945.5%August 2, 2025 | marketbeat.comXenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 1, 2025 | financialpost.comF Get Xenon Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for XENE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. XENE Media Mentions By Week XENE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XENE News Sentiment▼1.271.03▲Average Medical News Sentiment XENE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XENE Articles This Week▼106▲XENE Articles Average Week Get the Latest News and Ratings for XENE and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Xenon Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Ascendis Pharma A/S News QIAGEN News Moderna News BridgeBio Pharma News Elanco Animal Health News Verona Pharma PLC American Depositary Share News Roivant Sciences News Grifols News Revolution Medicines News Rhythm Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XENE) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xenon Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xenon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access